Stay updated on Fostamatinib in wAIHA Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in wAIHA Clinical Trial page.

Latest updates to the Fostamatinib in wAIHA Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedDifference1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.3.2 was applied. No substantive changes to the study details or page purpose are evident.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page adds Revision: v3.3.1 and removes Revision: v3.2.0; these are minor revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedRemoved the government funding lapse notice from the page, eliminating the external status guidance. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check67 days agoChange DetectedExpanded the Contacts and Locations section with additional recruitment sites across multiple countries, increasing the total number of participating locations.SummaryDifference0.3%

- Check95 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

Stay in the know with updates to Fostamatinib in wAIHA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in wAIHA Clinical Trial page.